Filing Flows › United Guardian (UG) › Q2 2026 › vs Q1 2026
United Guardian (UG) Q2 2026 vs Q1 2026 (quarter over quarter)
United Guardian's revenue rose $236K (+8%) from $2.9M in Q1 2026 to $3.1M in Q2 2026. The biggest changes: Cosmetic Ingredients +$443K (+52%); Medical −$230K (-39%); Pharmaceuticals +$23K (+2%). Operating margin 24.3% against 22.4% (+1.9 pts).
United Guardian, Q2 2026: revenue $3.1M (+10% year over year), operating margin 24.3%, net earnings $729K, operating cash flow $1.5M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Operating margin | 24.3% | 22.4% | +1.9 pts |
| Net margin | 23.4% | 28.5% | -5.1 pts |
| Free cash flow margin | 48.3% | 20.7% | +27.6 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Pharmaceuticals | $1.5M | $1.4M | $23K | +2% |
| Cosmetic Ingredients | $1.3M | $844K | $443K | +52% |
| Medical | $353K | $583K | −$230K | -39% |
| Revenue | $3.1M | $2.9M | $236K | +8% |
| Other income, net | $163K | $391K | −$227K | -58% |
| Operating profit | $754K | $642K | $112K | +17% |
| Costs & expenses | $2.4M | $2.2M | $124K | +6% |
| Pre-tax earnings | $918K | $1.0M | −$116K | -11% |
| Cost of revenue | $1.6M | $1.4M | $115K | +8% |
| Research & development | $124K | $115K | $9K | +8% |
| Other operating costs | $667K | $667K | $319 | 0% |
| Net earnings | $729K | $819K | −$90K | -11% |
| Income tax | $189K | $214K | −$25K | -12% |
| Depreciation & amortization | $29K | $29K | $358 | +1% |
| Working capital & other | $762K | −$243K | $1.0M | — |
| Operating cash flow | $1.5M | $605K | $915K | +151% |
| Free cash flow (OCF − capex) | $1.5M | $595K | $906K | +152% |
| Capital expenditures | $19K | $10K | $9K | +93% |
Questions
How much did United Guardian's revenue grow quarter over quarter in Q2 2026?
United Guardian's revenue rose $236K (+8%) from $2.9M in Q1 2026 to $3.1M in Q2 2026.
What drove United Guardian's revenue change in Q2 2026?
Cosmetic Ingredients +$443K (+52%); Medical −$230K (-39%); Pharmaceuticals +$23K (+2%).